Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Lisa D. Watkinson"'
Autor:
Santosh R. Alluri, Yusuke Higashi, Ashley Berendzen, Laurel A. Grisanti, Lisa D. Watkinson, Kamlendra Singh, Timothy J. Hoffman, Terry Carmack, Elizabeth A. Devanny, Miles Tanner, Kun-Eek Kil
Publikováno v:
EJNMMI Research, Vol 13, Iss 1, Pp 1-17 (2023)
Abstract Background CXCR3 is a chemokine receptor and is expressed in innate and adaptive immune cells. It promotes the recruitment of T-lymphocytes and other immune cells to the inflammatory site in response to the binding of cognate chemokines. Upr
Externí odkaz:
https://doaj.org/article/73c5c4708f6f4cbca64b73a63ab736cb
Autor:
Li Ma, Cameron Grant, Fabio Gallazzi, Lisa D. Watkinson, Terry L. Carmack, Mary F. Embree, C. Jeff Smith, Dmitri Medvedev, Cathy S. Cutler, Yawen Li, D. Scott Wilbur, Heather M. Hennkens, Silvia S. Jurisson
Publikováno v:
Nuclear Medicine and Biology. :61-69
Autor:
Fabio Gallazzi, Lisa D. Watkinson, Emily A. Fergason-Cantrell, Terry L. Carmack, John R. Lever
Publikováno v:
Nuclear Medicine and Biology. 70:53-66
Introduction Peripheral mu (μ) opioid receptors are implicated in pain, bowel dysfunction and the progression of certain cancers. In an effort to identify radioligands well suited for imaging these peripheral sites, we have prepared and evaluated fo
Autor:
Terry L. Carmack, Silvia S. Jurisson, Lauren Radford, Fabio Gallazzi, Dionysia Papagiannopoulou, Michael R. Lewis, Lisa D. Watkinson, Heather M. Hennkens, Ashley F. Berendzen
Publikováno v:
Bioorganic & Medicinal Chemistry. 27:492-501
The somatostatin receptor subtype 2 (SSTR2) is often highly expressed on neuroendocrine tumors (NETs), making it a popular in vivo target for diagnostic and therapeutic approaches aimed toward management of NETs. In this work, an antagonist peptide (
Autor:
Lisa D. Watkinson, Terry L. Carmack, Charles J. Smith, Emily A Fergason Cantrell, Anil Malhotra, Michael R. Lewis, Rajendra P. Bandari
Publikováno v:
Journal of medicinal chemistry. 64(4)
In this study, we describe the development of heterobivalent [DUPA-6-Ahx-([111In]In-DO3A)-8-Aoc-BBN ANT] and [DUPA-6-Ahx-([177Lu]Lu-DO3A)-8-Aoc-BBN ANT] radiotracers that display very high selectivity/specificity for gastrin-releasing peptide recepto
Autor:
Lisa D. Watkinson, Fabio Gallazzi, Silvia S. Jurisson, Ashley F. Berendzen, Heather M. Hennkens, Terry L. Carmack, Lauren Radford, Michael R. Lewis, Dionysia Papagiannopoulou
Publikováno v:
Nuclear Medicine and Biology. 47:4-9
Introduction A somatostatin receptor (SSTR)-targeting antagonist peptide (sst 2 -ANT) was radiolabeled with 99m Tc tricarbonyl via a tridentate [N,S,N]-type ligand (L) to develop a radiodiagnostic agent, 99m TcL-sst 2 -ANT, for imaging of SSTR-expres
Autor:
Maryna Kuchuk, Cathy S. Cutler, Sudarshan K. Loyalka, Terry L. Carmack, Kattesh V. Katti, Lisa D. Watkinson, Menka Khoobchandani, Amal Yousif Al-Yasiri, Ademar B. Lugão, Charles J. Smith
Publikováno v:
Dalton Transactions. 46:14561-14571
We report here an innovative feature of green nanotechnology-focused work showing that mangiferin—a glucose functionalized xanthonoid, found in abundance in mango peels—serves dual roles of chemical reduction and in situ encapsulation, to produce
Autor:
Terry L. Carmack, John R. Lever, Emily A. Fergason-Cantrell, Dennis K. Miller, Lisa D. Watkinson, Susan Z. Lever, Sarah A. Lord, Rong Xu
Publikováno v:
Synapse. 70:98-111
Activation of sigma1 (σ1) receptors contributes to the behavioral and toxic effects of (-)-cocaine. We studied a key step, the ability of (-)-cocaine to occupy σ1 receptors in vivo, using CD-1(®) mice and the novel radioligand [(125) I]E-N-1-(3'-i
Autor:
John R, Lever, Emily A, Fergason-Cantrell, Terry L, Carmack, Lisa D, Watkinson, Fabio, Gallazzi
Publikováno v:
Nuclear medicine and biology. 70
INTRODUCTION: Peripheral mu (μ) opioid receptors are implicated in pain, bowel dysfunction and the progression of certain cancers. In an effort to identify radioligands well suited for imaging these peripheral sites, we have prepared and evaluated f
Autor:
Nripen Chanda, Para Kan, Lisa D. Watkinson, Ravi Shukla, Ajit Zambre, Terry L. Carmack, Hendrik Engelbrecht, John R. Lever, Kavita Katti, Genevieve M Fent, Stan W. Casteel, C. Jeffrey Smith, William H. Miller, Silvia Jurisson, Evan Boote, J.David Robertson, Cathy Cutler, Marina Dobrovolskaia, Raghuraman Kannan, Kattesh V. Katti
Publikováno v:
Nanomedicine in Cancer ISBN: 9781315114361
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ed18e5d5f6e69dc19919d2baf34e0c8
https://doi.org/10.1201/b22358-31
https://doi.org/10.1201/b22358-31